Sym021

· Symphogen A/S

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Sym021, covering 2024-06-26 to 2026-03-13. Get the full timeline:

Most recent: Clinical Trial Update: S095029 as Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies Followed by an Expansion Part With Triple Combinations in Patients With Metastatic Gastric or Colorectal Cancers [Phase 1]

See pricing